Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2011-10-24
- Lead Sponsor
- Biosynexus Incorporated
- Target Recruit Count
- 1579
- Registration Number
- NCT00646399
- Locations
- 🇺🇸
Biosynexus Incorporated, Gaithersburg, Maryland, United States
Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants
- First Posted Date
- 2008-03-14
- Last Posted Date
- 2008-10-09
- Lead Sponsor
- Biosynexus Incorporated
- Target Recruit Count
- 8
- Registration Number
- NCT00636285
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110
- First Posted Date
- 2008-03-10
- Last Posted Date
- 2008-03-10
- Lead Sponsor
- Biosynexus Incorporated
- Target Recruit Count
- 88
- Registration Number
- NCT00631800
- Locations
- 🇺🇸
Texas Children's Hospital/Ben Taub Hospital (Baylor College of Medicine), Houston, Texas, United States
Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110
Phase 1
Completed
- Conditions
- Neonatal Staphylococcal Sepsis
- Interventions
- First Posted Date
- 2008-03-10
- Last Posted Date
- 2008-03-10
- Lead Sponsor
- Biosynexus Incorporated
- Target Recruit Count
- 53
- Registration Number
- NCT00631878
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath